Management Team
Henning von Koss: Chief Executive Officer
During his 27 years with Bayer Material Science, Mr. von Koss served as senior vice president of Latin America, president and head of healthcare in the Andean region, and in numerous management positions in Brazil, Germany and Poland in addition to the Andean region. He recently served as chief operating officer of HAPVIDA, the third-largest managed care organization in Brazil with 20 hospitals, 70 clinics, 50 labs and 17,000+ employees, generating $3 billion turnover.
Ian D. Atacan, CPA, CMA, MBA: Chief Financial Officer
Mr. Atacan is a finance leader with more than 25 years of public company experience in strategy, M&A, and financing. He has worked in Europe and Canada with renowned international companies such as Sprint, Alcatel, DHL Worldwide Express, and Procter & Gamble. Most recently, Mr. Atacan was the CFO of Blueberries Medical Corp. a licensed cannabis producer in Colombia. Previously he was the CFO of Natura Naturals Inc., a Canadian cannabis company, until its acquisition by Tilray Inc. (NASDAQ: TLRY). Prior to that, Mr. Atacan served as the CFO of Global Atomic Corporation (TSX: GLO). Mr. Atacan is a Chartered Professional Accountant (CPA, CMA), MBA (London, UK) and Electrical & Electronics Engineer.
Andrés Felipe Botero: Chief Operating Officer PharmaCielo Colombia
Mr. Botero was head of Philip Morris Andean Cluster for 20 years, overseeing cultivation, manufacturing, quality assurance, supply chain and distribution, and served as manager of Philip Morris International’s operations for reduced risk product portfolio in Colombia.
Board of Directors
Bill Petron, Chairman of the Board
Mr. Petron has a diverse and successful background scaling global manufacturing, logistics and medical cannabis operations. Most recently, Mr. Petron co-founded Alternative Medical Enterprises LLC, and co-led the company through its December 2020 merger with Verano Holdings LLC. and it subsequent public offering on the CSE in February 2021. Mr. Petron founded MSI Integrated Solutions headquartered in Porto Alegre, Brazil (1999); and Magnus Logistics Solutions Inc. headquartered in Toronto, Ontario (2006).
Marc Lustig, Lead Director
Mr. Lustig founded CannaRoyalty Corp. (Origin House), which was sold to Cresco Labs in 2020, is currently executive chairman of IMC Cannabis, chairman of Trichome Financial Corp. and director of Cresco Labs. He served in the capital markets sector for 15 years, as director at GMP Securities, head of Capital Markets at Dundee Capital Markets and in the Life Sciences sector at Orion Securities. Previously, he worked in the pharmaceutical industry with Merck & Co.
Doug Bache, Director, Audit Committee Chair
Mr. Bache is a director and management consultant providing corporate finance and strategic advisory services to private and public companies. He has held senior management positions at Vale/Inco Limited and North American Palladium and investment and corporate banking roles with CIBC World Markets and Société Générale Canada.
Dr. Claudia Jiménez, Director
Dr. Jiménez is a lawyer with Jiménez & Asociados S.A.S., a private consultancy firm. She has served as Minister-Counselor for the President of Colombia, Ambassador in Switzerland and Liechtenstein, Executive Director of the Mining Colombian Association (SMGE) and Professor at the University Externado de Colombia and is a member of the board of ISA InterColombia, Executive Director of the Dialogue Group of Mining in Colombia (GDIAM) and a former board member of Empresas Públicas de Medellín (EPM) and TSX-listed Continental Gold. She completed a Doctorate of Law at the Université of Paris II (Panthéon-Assas), France and Law and Political Science degree at the Universidad Pontificia Bolivariana in Medellín.
Matteo Pellegrini, Director
Mr. Pellegrini has over 25 years of international management and leadership experience with Philip Morris International in numerous European and Asian countries. He served from 2003 to 2015 as Philip Morris International’s president of Asia.
Henning von Koss, Director
During his 27 years with Bayer Material Science, Mr. von Koss served as senior vice president of Latin America, president and head of healthcare in the Andean region, and in numerous management positions in Brazil, Germany and Poland in addition to the Andean region. He recently served as chief operating officer of HAPVIDA, the third-largest managed care organization in Brazil with 20 hospitals, 70 clinics, 50 labs and 17,000+ employees, generating $3 billion turnover.
